methoxyhydroxyphenylglycol has been researched along with Alzheimer Disease in 66 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 33 (50.00) | 18.7374 |
1990's | 20 (30.30) | 18.2507 |
2000's | 3 (4.55) | 29.6817 |
2010's | 6 (9.09) | 24.3611 |
2020's | 4 (6.06) | 2.80 |
Authors | Studies |
---|---|
Guimarães, J; Henriques, T; Portela Moreira, I; Vieira-Coelho, MA | 1 |
Abe, K; Furuya, S; Ichinose, T; Ishijima, T; Matsui, T; Matsumoto, S; Murasawa, H; Okada, S | 1 |
Jacobs, HIL; Riphagen, JM; van Egroo, M | 1 |
Jacobs, HIL; Jansen, WJ; Ramakers, IHGB; van Hooren, RWE; Verhey, FRJ | 1 |
Berretta, N; Cavallucci, V; D'Amelio, M; Mercuri, NB; Nisticò, R; Nobili, A | 1 |
Aerts, MB; Bloem, BR; Claassen, JAHR; Esselink, RAJ; Herbert, MK; Kuiperij, HB; Spies, PE; Verbeek, MM | 1 |
Aerts, T; De Deyn, PP; Engelborghs, S; Van Dam, D; Vermeiren, Y | 1 |
Aerts, T; Coppus, AM; De Deyn, PP; Dekker, AD; Kremer, BP; Naudé, PJ; Van Dam, D; van Duijn, CM; Vermeiren, Y | 1 |
Kawashima, T; Kojima, N; Kunitake, Y; Li, GY; Muraoka, T; Sugataka, K; Watanabe, I; Yamada, S | 1 |
Ehrlich, ME; Fraser, PE; Gandy, S; Kim, SH; St George-Hyslop, PH; Westaway, D | 1 |
Abdo, WF; Aerts, MB; Bloem, BR; Claassen, JA; Esselink, RA; Verbeek, MM | 1 |
Goldstein, DS; Holmes, C; Kopin, IJ; Patronas, N | 1 |
Sanada, H; Yoneda, M | 1 |
Cajal, S; Etienne, P; Gauthier, S; Lal, S; Nair, NP; Wood, PL | 1 |
Adolfsson, R; Aquilonius, SM; Carlsson, A; Eckernäs, SA; Gottfries, CG; Nordberg, A; Oreland, L; Svennerholm, L; Wiberg, A; Winblad, B | 1 |
Bowen, DM; Davison, AN; Neary, D; Palmer, AM; Palo, J; Sims, NR; Wikstrom, J | 1 |
Aguado, EG; de Yebenes, JG; Mena, MA | 1 |
Davis, KL; Losonczy, MF; Mohs, RC | 1 |
Mann, DM | 1 |
Halter, JB; Jimerson, DC; Peskind, ER; Raskind, MA | 1 |
de Leon, MJ; Ferris, SH; Gershon, S; Mann, JJ; Neophytides, A; Stanley, M | 1 |
Bierer, LM; Davis, KL; Knott, PJ; Lawlor, BA; Mohs, RC; Ryan, TM; Schmeidler, J; Williams, LL | 1 |
Alhainen, K; Helkala, EL; Reinikainen, K; Riekkinen, P | 1 |
Hill, JL; Minichiello, M; Molchan, SE; Sunderland, T; Vitiello, B | 1 |
Ahlskog, JE; Kokmen, E; O'Brien, JF; Petersen, RC; Tyce, GM; Uitti, RJ | 1 |
Bardgett, ME; Csernansky, JG; Miller, K; Sheline, YI | 1 |
Wada, H | 1 |
Goldstein, DS; Holmes, C; Peskind, ER; Raskind, MA | 1 |
Blandini, F; Bono, G; Martignoni, E; Nappi, G; Pacchetti, C; Petraglia, F | 1 |
Dyon-Laurent, C; Guibert, B; Leviel, V; Sara, SJ | 1 |
Nakamura, S | 1 |
Kawakatsu, S; Kobashi, K; Morinobu, S; Shinohara, M; Totsuka, S | 1 |
Gottfries, CG; Nyth, AL | 1 |
Adolfsson, R; Ekstedt, J; Kristensen, B; Malm, J; Wester, P | 1 |
Blandini, F; Bono, G; Martignoni, E; Merlo, P; Nappi, G; Sinforiani, E | 1 |
Hill, JL; Lawlor, BA; Martinez, R; Mellow, AM; Molchan, SE; Sunderland, T | 1 |
Davis, CL; Hill, JL; Lawlor, BA; Martinez, RA; Mellow, AM; Molchan, SE; Rubinow, DR; Sunderland, T | 1 |
Berrettini, WH; Cohen, RM; Lawlor, BA; Martinez, RA; Molchan, SE; Sunderland, T; Tariot, PN; Vitiello, B | 1 |
Blomqvist, G; Nybäck, H; Nyman, H; Sjögren, I; Stone-Elander, S | 1 |
Chang, YF; Chi, CW; Liu, HC; Liu, TY; Yang, JC | 1 |
Davis, CL; Hill, JL; Lawlor, BA; Martinez, R; Mellow, AM; Molchan, SE; Sunderland, T | 1 |
Dalesio, O; Desmedt, D; Hildebrand, J; Messina, D; Seeldrayers, P | 1 |
Costa, JL; Cutler, NR; Haxby, J; Kay, AD; Lesko, LJ; Linnoila, M; Narang, PK; Ninos, M; Potter, WZ; Renfrew, JW | 1 |
Davis, BM; Davis, KL; Greenwald, BS; Horvath, TB; Johns, CA; Mathé, AA; Mohs, RC | 2 |
Creasey, H; Cutler, NR; Haxby, JV; Kaufman, S; Kay, AD; Milstien, S; Rapoport, SI | 1 |
Bowen, DM; Esiri, MM; Francis, PT; Palmer, AM; Wilcock, GK | 1 |
Cohen, RM; Mellow, AM; Mueller, EA; Murphy, DL; Newhouse, PA; Sunderland, T; Tariot, PN | 1 |
Cote, L; Mayeux, R; Sano, M; Stern, Y; Williams, JB | 1 |
Gottfries, CG; Gottfries, J; Karlsson, I; Långström, G; Parnetti, L; Svennerholm, L | 1 |
Nybäck, H; Nyman, H; Schalling, D | 1 |
Atack, JR; Daly, E; Friedland, RP; Kaufman, S; Kay, AD; Kaye, JA; Luxenberg, JS; May, C; Milstien, S; Sweeney, DJ | 1 |
Ishizaki, T; Koyama, E; Minegishi, A | 1 |
Corkin, S; Freed, DM; Growdon, JH; Nissen, MJ | 1 |
Atack, JR; Beal, MF; Daly, E; Friedland, RP; Kaufman, S; Kaye, JA; May, C; Milstien, S; Rapoport, SI; Sweeney, DL | 1 |
Helkala, EL; Jolkkonen, J; Kutvonen, R; Lehtinen, M; Riekkinen, PJ | 1 |
Blennow, K; Bråne, G; Gottfries, CG; Karlsson, I; Lekman, A; Parnetti, L; Svennerholm, L; Wallin, A | 1 |
Corona, GL; Cucchi, ML; Frattini, P; Pola, A; Romani, A; Santagostino, G; Savoldi, F; Schinelli, S; Zerbi, F | 1 |
Gottfries, CG | 1 |
Gibson, CJ; Growdon, JH; Logue, M | 1 |
Bowen, DM; Davison, AN; Esiri, MM; Francis, PT; Neary, D; Palmer, AM; Sims, NR; Snowden, JS; Wilcock, GK | 1 |
Shigetomi, S | 1 |
Albert, ML; Bird, ED; Direnfeld, LK; Freedman, M; Langlais, PJ; Volicer, L | 1 |
Eisenhofer, G; Goldstein, DS; Keiser, HR; Kopin, IJ; Murphy, DL; Stull, R; Sunderland, T | 1 |
Bagne, CA; Deptula, D; Galloway, MP; Pomara, N; Rhiew, HB; Stanley, M; Tamminga, CA; Tanimoto, K; Verebey, K | 1 |
Benton, JS; Bowen, DM; Francis, PT; Mann, DM; Neary, D; Palmer, AM; Snowden, JS | 1 |
4 review(s) available for methoxyhydroxyphenylglycol and Alzheimer Disease
Article | Year |
---|---|
Dysfunction of norepinephrine and its metabolites in Alzheimer's dementia - A review with meta-analysis.
Topics: Alzheimer Disease; Humans; Methoxyhydroxyphenylglycol; Norepinephrine | 2023 |
[3-methoxy-4-hydroxyphenylglycol (MHPG)].
Topics: Alzheimer Disease; Anorexia Nervosa; Biomarkers; Bipolar Disorder; Chromatography, High Pressure Liquid; Depression; Fatigue Syndrome, Chronic; Gas Chromatography-Mass Spectrometry; Humans; Methoxyhydroxyphenylglycol; Norepinephrine; Reference Values; Schizophrenia; Specimen Handling | 2005 |
The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system.
Topics: Adult; Aged; Aging; Alzheimer Disease; Cerebral Palsy; Cytoskeleton; Dementia; Down Syndrome; Humans; Locus Coeruleus; Melanins; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease | 1983 |
The dexamethasone suppression test in Alzheimer's disease and major depression: relationship to dementia severity, depression, and CSF monoamines.
Topics: Aged; Alzheimer Disease; Depressive Disorder; Dexamethasone; Female; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Hypothalamo-Hypophyseal System; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Pituitary-Adrenal System | 1990 |
7 trial(s) available for methoxyhydroxyphenylglycol and Alzheimer Disease
Article | Year |
---|---|
CSF tau, Aβ42, and MHPG differentiate dementia with Lewy bodies from Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Female; Humans; Lewy Body Disease; Male; Methoxyhydroxyphenylglycol; Middle Aged; Peptide Fragments; Retrospective Studies; tau Proteins | 2011 |
Scopolamine effects on the pressor response to thyrotropin-releasing hormone in humans.
Topics: Aged; Alzheimer Disease; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Scopolamine; Thyrotropin-Releasing Hormone | 1994 |
The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.
Topics: Affective Symptoms; Aged; Alzheimer Disease; Citalopram; Dementia, Multi-Infarct; Double-Blind Method; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Neuropsychological Tests; Scandinavian and Nordic Countries | 1990 |
Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl.
Topics: Aged; Alzheimer Disease; Biogenic Monoamines; Cognition; Dopamine; Double-Blind Method; Epinephrine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Norepinephrine; Psychiatric Status Rating Scales; Psychological Tests; Selegiline | 1991 |
Evaluation of zimeldine in Alzheimer's disease. Cognitive and biochemical measures.
Topics: Aged; Alzheimer Disease; Blood Platelets; Clinical Trials as Topic; Double-Blind Method; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Memory; Methoxyhydroxyphenylglycol; Middle Aged; Placebos; Psychological Tests; Reaction Time; Serotonin; Zimeldine | 1985 |
Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arousal; Blood Pressure; Choline; Clinical Trials as Topic; Dementia, Multi-Infarct; Drug Therapy, Combination; Female; Glycols; Heart Rate; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Memory; Mental Recall; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Norepinephrine; Piracetam; Pyrrolidinones | 1989 |
Loss of the cortisol response to naltrexone in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Naltrexone; Prolactin | 1988 |
55 other study(ies) available for methoxyhydroxyphenylglycol and Alzheimer Disease
Article | Year |
---|---|
Tyr-Trp administration facilitates brain norepinephrine metabolism and ameliorates a short-term memory deficit in a mouse model of Alzheimer's disease.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Catecholamines; Cerebral Cortex; Dipeptides; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; Humans; Male; Memory, Short-Term; Metabolome; Methoxyhydroxyphenylglycol; Mice; Peptide Fragments | 2020 |
Elevated Norepinephrine Metabolism Gauges Alzheimer's Disease-Related Pathology and Memory Decline.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Humans; Learning; Locus Coeruleus; Male; Memory Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Norepinephrine; Predictive Value of Tests; tau Proteins | 2021 |
Elevated norepinephrine metabolism is linked to cortical thickness in the context of Alzheimer's disease pathology.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Cerebral Cortex; Cognition; Female; Humans; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Middle Aged; Nerve Degeneration; Norepinephrine; Organ Size; Peptide Fragments; tau Proteins | 2021 |
Calcineurin inhibition rescues early synaptic plasticity deficits in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; CA1 Region, Hippocampal; Calcineurin Inhibitors; Caspase 3; Dendrites; Disease Models, Animal; Disks Large Homolog 4 Protein; Drug Evaluation, Preclinical; Excitatory Postsynaptic Potentials; Guanylate Kinases; Long-Term Synaptic Depression; Male; Membrane Proteins; Methoxyhydroxyphenylglycol; Mice; Mice, Transgenic; Neuroprotective Agents; Phosphorylation; Phosphoserine; Post-Synaptic Density; Protein Processing, Post-Translational; Receptors, AMPA; Receptors, Metabotropic Glutamate; Tacrolimus | 2013 |
Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Female; Humans; Lewy Body Disease; Logistic Models; Male; Methoxyhydroxyphenylglycol; Middle Aged; Peptide Fragments; Retrospective Studies; Sensitivity and Specificity; tau Proteins | 2014 |
Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Brain; Chromatography, High Pressure Liquid; Depression; Dopamine; Epinephrine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Serotonin | 2014 |
Serum MHPG strongly predicts conversion to Alzheimer's disease in behaviorally characterized subjects with Down syndrome.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Disease Progression; Dopamine; Down Syndrome; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Peptide Fragments | 2015 |
Relationship between saliva level of 3-methoxy-4-hydroxyphenylglycol and mental health in the elderly general population.
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Depressive Disorder; Female; Humans; Male; Mental Status Schedule; Methoxyhydroxyphenylglycol; Neuropsychological Tests; Norepinephrine; Personality Inventory; Psychometrics; Reference Values; Saliva; Sex Factors; Statistics as Topic | 2008 |
Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals.
Topics: Alzheimer Disease; Amino Acids; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Humans; Methoxyhydroxyphenylglycol; Mice; Mice, Transgenic; Nerve Endings; Peptide Fragments; Receptors, Metabotropic Glutamate; Signal Transduction; Xanthenes | 2010 |
Cerebrospinal fluid levels of catechols in patients with neurogenic orthostatic hypotension.
Topics: Aged; Alzheimer Disease; Autonomic Nervous System Diseases; Case-Control Studies; Catechols; Chronic Disease; Humans; Hypotension, Orthostatic; Linear Models; Male; Methoxyhydroxyphenylglycol; Multiple System Atrophy; Norepinephrine | 2003 |
Reduced lumbar CSF somatostatin levels in Alzheimer's disease.
Topics: Aged; Alcohol Amnestic Disorder; Alzheimer Disease; Dementia; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia; Somatostatin | 1982 |
Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT).
Topics: Aged; Alzheimer Disease; Brain; Choline O-Acetyltransferase; Female; Gangliosides; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Isoenzymes; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Neurofibrils; Neurotransmitter Agents; Receptors, Muscarinic; Serotonin | 1983 |
Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
Topics: Aged; Alzheimer Disease; Brain; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Lumbosacral Region; Male; Methoxyhydroxyphenylglycol; Middle Aged; Phenylacetates | 1984 |
Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alzheimer Disease; Chromatography, High Pressure Liquid; Depression; Dihydroxyphenylalanine; Electrochemistry; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Parkinson Disease; Phenylacetates; Subarachnoid Hemorrhage; Tryptophan; Tyrosine | 1984 |
Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations.
Topics: Adult; Alzheimer Disease; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurotransmitter Agents; Schizophrenia; Seasons | 1984 |
Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Blood-Brain Barrier; Brain; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Norepinephrine | 1984 |
Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit.
Topics: Aged; Alzheimer Disease; Blood Platelets; Cognition Disorders; Dementia; Glycols; Homovanillic Acid; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Phenylacetates; Tomography, X-Ray Computed | 1981 |
Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer's disease.
Topics: Affective Symptoms; Aged; Aged, 80 and over; Alzheimer Disease; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Norepinephrine | 1995 |
The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Biogenic Monoamines; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Tacrine | 1993 |
Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Alzheimer Disease; Blood Platelets; Catecholamines; Epinephrine; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Norepinephrine; Parkinson Disease | 1996 |
Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type. Relationship with cognitive dysfunction.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Serotonin; Severity of Illness Index | 1998 |
Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio.
Topics: Aged; Aged, 80 and over; Albumins; alpha 1-Antichymotrypsin; Alzheimer Disease; Blood-Brain Barrier; Case-Control Studies; Dementia; Dementia, Vascular; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Serum Albumin | 1998 |
Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aged; Aging; Alzheimer Disease; Antimetabolites; Catechols; Chromatography, High Pressure Liquid; Clonidine; Cognition Disorders; Dihydroxyphenylalanine; Extracellular Space; Female; Humans; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Neurons; Neuropsychological Tests; Norepinephrine; Yohimbine | 1999 |
Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type.
Topics: Adult; Aged; Alzheimer Disease; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropeptide Y; Norepinephrine; Parkinson Disease; Peripheral Nervous System Diseases; Severity of Illness Index; Shy-Drager Syndrome; Spinal Cord Diseases | 1992 |
Noradrenergic hyperactivity after partial fornix section: role in cholinergic dependent memory performance.
Topics: Alzheimer Disease; Animals; Benzylamines; Choline O-Acetyltransferase; Hippocampus; Male; Memory; Methoxyhydroxyphenylglycol; Neurotoxins; Norepinephrine; Rats; Rats, Inbred Strains; Reference Values | 1992 |
[Alzheimer's disease and neurotransmitters].
Topics: Acetylcholine; Acetylcholinesterase; Alzheimer Disease; Amino Acids; Animals; Brain; Choline O-Acetyltransferase; Dopamine; Humans; Methoxyhydroxyphenylglycol; Neuropeptides; Neurotransmitter Agents; Norepinephrine; Serotonin | 1991 |
Acetylcholinesterase activities and monoamine metabolite levels in the cerebrospinal fluid of patients with Alzheimer's disease.
Topics: Acetylcholinesterase; Adult; Aged; Alzheimer Disease; Brain; Butyrylcholinesterase; Cerebral Ventricles; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Neurotransmitter Agents; Tomography, X-Ray Computed | 1990 |
CSF monoamine metabolites, cholinesterases and lactate in the adult hydrocephalus syndrome (normal pressure hydrocephalus) related to CSF hydrodynamic parameters.
Topics: Aged; Alzheimer Disease; Cerebrospinal Fluid Pressure; Cholinesterases; Dementia, Multi-Infarct; Female; Homovanillic Acid; Humans; Hydrocephalus, Normal Pressure; Hydroxyindoleacetic Acid; Lactates; Lactic Acid; Male; Methoxyhydroxyphenylglycol; Neurologic Examination; Neuropsychological Tests; Neurotransmitter Agents; Tomography, X-Ray Computed | 1991 |
CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
Topics: Aged; Alzheimer Disease; Depressive Disorder; Diagnosis, Differential; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Peptides; Psychiatric Status Rating Scales | 1991 |
Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Depressive Disorder; Dynorphins; Female; Galanin; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Recall; Methoxyhydroxyphenylglycol; Middle Aged; Neuropeptide Y; Neuropsychological Tests; Peptide Fragments; Peptides; Receptors, Opioid; Vasoactive Intestinal Peptide | 1991 |
Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects.
Topics: Aged; Alzheimer Disease; Blood Glucose; Brain; Brain Mapping; Cerebral Cortex; Deoxyglucose; Dominance, Cerebral; Energy Metabolism; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Neurotransmitter Agents; Tomography, Emission-Computed | 1991 |
Analysis of monoamines in the cerebrospinal fluid of Chinese patients with Alzheimer's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alzheimer Disease; China; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Epinephrine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Isoproterenol; Metanephrine; Methoxyhydroxyphenylglycol; Norepinephrine; Vanilmandelic Acid | 1991 |
The TRH stimulation test in Alzheimer's disease and major depression: relationship to clinical and CSF measures.
Topics: Aged; Alzheimer Disease; Depressive Disorder; Diagnosis, Differential; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Peptides; Radioimmunoassay; Thyroid Function Tests; Thyrotropin; Thyrotropin-Releasing Hormone | 1991 |
CSF levels of neurotransmitters in Alzheimer-type dementia. Effects of ergoloid mesylate.
Topics: Aged; Alzheimer Disease; Dihydroergotoxine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurotransmitter Agents; Psychometrics | 1985 |
Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studies.
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Choline; Choline Deficiency; Cognition; Female; Gas Chromatography-Mass Spectrometry; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Tomography, X-Ray Computed | 1985 |
Cerebrospinal fluid biopterin is decreased in Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Biopterins; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Pteridines; Serotonin | 1986 |
Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Biogenic Amines; Dopamine; Female; Frontal Lobe; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Serotonin; Temporal Lobe | 1987 |
Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Biogenic Amines; Dose-Response Relationship, Drug; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Phenethylamines; Selegiline | 1987 |
Clinical and biochemical correlates of bradyphrenia in Parkinson's disease.
Topics: Aged; Alzheimer Disease; Arousal; Attention; Biogenic Amines; Cognition Disorders; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Parkinson Disease | 1987 |
Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography-mass spectrometry.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biogenic Amines; Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia | 1987 |
Neuropsychological test performance and CSF levels of monoamine metabolites in healthy volunteers and patients with Alzheimer's dementia.
Topics: Aged; Alzheimer Disease; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Psychometrics | 1987 |
Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features.
Topics: Aged; Alzheimer Disease; Biopterins; Dementia; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Pyramidal Tracts | 1988 |
Simultaneous determination of four monoamine metabolites and serotonin in cerebrospinal fluid by "high-performance" liquid chromatography with electrochemical detection; application for patients with Alzheimer's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alzheimer Disease; Chromatography, High Pressure Liquid; Electrochemistry; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methods; Methoxyhydroxyphenylglycol; Phenylacetates; Reference Standards; Serotonin | 1988 |
Selective attention in Alzheimer's disease: CSF correlates of behavioral impairments.
Topics: Aged; Alzheimer Disease; Attention; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Neuropsychological Tests | 1988 |
Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's disease.
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Analysis of Variance; Biopterins; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Myoclonus | 1988 |
Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance.
Topics: Aged; Alzheimer Disease; Arginine Vasopressin; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Recall; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests | 1989 |
Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.
Topics: Aged; Alzheimer Disease; Behavior; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Reference Values | 1989 |
Neurotransmitters in the brains of patients with dementia disorders.
Topics: Acetylcholine; Aged; Alzheimer Disease; Brain; Choline O-Acetyltransferase; Dementia; Dopamine; Glutamate Decarboxylase; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Neurotransmitter Agents; Norepinephrine; Serotonin | 1985 |
CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease.
Topics: Adult; Aged; Alzheimer Disease; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Phenylacetates; Probenecid | 1985 |
Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.
Topics: Acetylcholine; Age Factors; Aged; Alzheimer Disease; Brain; Choline O-Acetyltransferase; Cholinergic Fibers; Cognition; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Neurotransmitter Agents; Norepinephrine; Parasympathomimetics; Serotonin; Temporal Lobe | 1985 |
[Clinical significance of 3-methoxy-4-hydroxyphenylethylene glycol analysis in endocrine tests of the medulla and sympathetic nervous system].
Topics: Adrenal Medulla; Alzheimer Disease; Anorexia Nervosa; Chromatography, Gas; Chromatography, High Pressure Liquid; Depressive Disorder; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Reference Values; Schizophrenia; Sympathetic Nervous System | 1989 |
Catecholamine metabolites and cyclic nucleotides in cerebrospinal fluid in dementia of Alzheimer type.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Alzheimer Disease; Catecholamines; Cyclic AMP; Cyclic GMP; Homovanillic Acid; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Nucleotides, Cyclic | 1985 |
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.
Topics: Alzheimer Disease; Animals; Catecholamines; Chromatography, Liquid; Depression; Dihydroxyphenylalanine; Dogs; Glycols; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Posture; Quality Control; Selegiline; Tranylcypromine | 1986 |
Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Catecholamines; Cerebral Cortex; Choline O-Acetyltransferase; Cognition Disorders; Dopamine; Female; Homovanillic Acid; Humans; In Vitro Techniques; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Serotonin | 1987 |
Cortisol and Alzheimer's disease, I: Basal studies.
Topics: Aged; Alzheimer Disease; Circadian Rhythm; Dexamethasone; Diagnosis, Differential; Female; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Sleep | 1986 |